Australian approved name (AAN): Pyridoxal 5-phosphate
Common names and synonyms:
Codecarboxylase
Pyridoxal 5-monophosphoric acid ester
Pyridoxal 5-phosphate anhydrous
Vitamin B6 phosphate
P5P
Vitamin B6
Molecular Formula: C8H10NO6P
Molecular weight: 247.14
Conversions (% pyridoxine): 68.45
RDI for Vitamin B6 as per NHMRC:
Infants – 0-6 months – 0.1mg/day
Infants – 7-12 months – 0.3mg/day
Children – 1-3 years – 0.5mg/day
Children – 4-8 years – 0.6mg/day
Children – 9-13 years – 1.0mg/day
Boys – 14-18 years – 1.3mg/day
Girls – 14–18 years – 1.2mg/day
Adults – 19 – 50 years – 1.3mg/day
Men – 51-70+ years – 1.7mg/day
Women – 51-70+ years – 1.5mg/day
Pregnancy – 1.9mg/day
Lactation – 2.0mg/day
Maximum daily dose: 200mg pyridoxine
Mandatory component: Pyridoxine
Warnings and Restrictions: The percentage of pyridoxine from pyridoxal 5-phosphate should be calculated based on the molecular weight of pyridoxal 5-phosphate.
If the medicine contains more than 50 mg and no more than 200 mg of pyridoxine per maximum recommended daily dose the medicine requires the following warning statement on the medicine label:
VITB6SX – WARNING – Stop taking this medication if you experience tingling, burning or numbness and see your healthcare practitioner as soon as possible. [Contains vitamin B6].
When used as an active ingredient and the route of administration is oral or sublingual, the medicine requires the following warning statement on the medicine label:
VIT – Vitamins can only be of assistance if the dietary vitamin intake is inadequate. or Vitamin supplements should not replace a balanced diet
Allowable purpose of the ingredient: Active. Excipient
TGA reference: Merk Index